UCSF

ACDRS 2021 Session 6: Integrated Product Development, Project Management, and Portfolio Management; Preparing for Transition to Market

Date: 
Monday, December 6, 2021 - 10:00 am to Friday, December 10, 2021 - 3:00 pm
Location: 
virtual/online

This is Session 6 of 6. Must register for the entire course and not per Session.

Session Chairperson: Charlie T. Gombar, PhD, ACDRS Director

Lecturers

Francine Del Ricci Global Head of Program Management, Endo International

Sue Duvall, RN, MPA

Consultant

Charlie T. Gombar, PhD

ACDRS Director

Richard Heaslip, PhD

President and Founder, Programmatic Sciences LLC

Craig H. Mallinckrodt, PhD

Senior Director, Research and Early Development Statistics, Biogen
Jennifer C. Power, MBA BioPharma Commercial Executive

Mary Frances Schubert, MD

Vice President and Chief Safety Officer, Global Clinical Safety and Pharmacovigilance, Merck Research Laboratories

Topics

  • Portfolio management: principles, challenges, and strategies
  • Role of licensing in portfolio management
  • Project management: principles, challenges, and strategies
  • Judgment under uncertainty
  • Integrated global strategy
  • Turning strategy into plans
  • Co-development and alliances
  • Strategic marketing (commercial) role in development
  • How to launch a new drug successfully into the market
  • Digital transformation and artificial intelligence
  • Prescription drug promotion
  • Promotional committee review simulation
  • Pharmacovigilance
  • Leadership strategies in drug development and regulation